Chrome 2001
.
The Trusted Source InteliHealth Aetna InteliHealth Aetna InteliHealth
Enter Drug Name . Enter Search Term
     
. .
. .
.
Home
Health Commentaries
InteliHealth Dental
Drug Resource Center
Ask the Expert
Interactive Tools

InteliHealth Policies
Site Map
Diseases & Conditions Healthy Lifestyle Your Health Look It Up
Health News Health News
.
.

This Week in Health
Our weekly round up of the latest news in the world of health.

A new stroke treatment that "vacuums" out clogged arteries, a new look at treating bulging arteries, and a compound that could prevent cerebral palsy in premature infants were in the news this week. So was an experimental flu vaccine that doesn't need needles.
Stay well.

This Issue:


New Treatment for Stroke
Fixing Bulging Arteries
Preventing CP in Preemies
Needle-Free Flu Vaccine

In the News:


New Treatment for Stroke

A device that works like a tiny vacuum may help some stroke victims. The Penumbra device, approved for use by the Food and Drug Administration last month, suctions clots out of the arteries of stroke victims. It could prevent brain damage in some patients who don't get treatment with the intravenous clot-busting drug TPA in time, The Associated Press reports. In a study of 125 patients, which will be presented at the February meeting of the American Stroke Association, Penumbra had few side effects and offered significant recovery benefits to 42 patients on whom it was used. But not all patients are good candidates, the AP quotes other experts as saying. The rush of blood to oxygen-deprived brain tissue can lead to potentially fatal swelling or hemorrhages. The U.S. National Institutes of Health is now funding a study involving 900 patients that will compare standard therapy with various inside-the-artery treatments, possibly including Penumbra.

Fixing Bulging Arteries


A less invasive procedure to repair bulging abdominal arteries may be better for older patients. A Harvard study, published in the New England Journal of Medicine, found that inserting a fabric sleeve into the artery, rather than traditional surgery to implant the arterial patch, led to fewer deaths among older patients. The study involved more than 45,000 Medicare patients, age 76 on average, who had abdominal aortic aneurysms. Nearly 5% of the patients who got traditional surgery died, versus only 1% of those who got the less invasive treatment. After four years, those in the non-invasive group were three times more likely to have an arterial rupture than the other patients, but this risk was offset by the other complications among people who got more invasive surgery, The Associated Press reports.

Preventing CP in Preemies


Giving mothers a simple compound of magnesium sulfate intravenously before birth can decrease the risk of cerebral palsy in preemies. A study presented at the Society for Maternal-Fetal Medicine meeting in Dallas this week suggests that there is a potential benefit to infuse intravenous magnesium sulfate in women delivering extremely premature babies. The study involved over 2,200 women who went into early labor at 24 to 31 weeks of pregnancy. The women were given either IV magnesium sulfate or a sterile placebo solution. The babies were checked for cerebral palsy at birth and over the next two years. Among the babies who survived, the researchers found moderate or severe cerebral palsy in about 2% of those whose mothers got treatment, compared to about 4% of those whose mothers got the dummy solution. The number of deaths was the same in both groups. The researchers could not say why magnesium sulfate works to prevent CP, but they theorize that it opens up blood vessels in newborns' brains. The compound is already widely used to treat pregnancy-related high blood pressure and stop preterm labor, The Associated Press reports.

Needle-Free Flu Vaccine


An experimental vaccine may one day protect children from the flu without using needles. A Korean study published online in the Proceedings of the National Academy of Sciences found that two doses of a liquid vaccine placed under the tongue offered protection against flu in mice. Placing the vaccine directly on mucus membranes prompted a response in both mucus tissues and the immune system, the researchers said. The researchers now are studying whether it will have the same benefit in humans, The Associated Press reports.

Used with the permission of the copyright owner. All rights reserved. The above summaries are not intended to provide advice on personal medical matters, nor are they intended to be a substitute for consultation with a physician.

.
InteliHealth
. . . .
.
More News
InteliHealth .
.
General Health
Top News
This Week In Health
Addiction
Allergy
Alzheimer's
Asthma
Arthritis
Babies
Breast Cancer
Cancer
Caregiving
Cervical Cancer
Children's Health
Cholesterol
Complementary & Alternative Medicine
Dental / Oral Health
Depression
Diabetes
Ear, Nose And Throat
Eyes
Family Health
Fitness
Headache
Heart Health
HIV / AIDS
Infectious Diseases
Lung Cancer
Medications
Men's Health
Mental Health
Nutrition News
Multiple Sclerosis
Nutrition Guide
Parkinson's
Pregnancy
Prevention
Prostate Cancer
Senior Health
Sexual / Reproductive Health
Sleep
Tobacco Cessation
STDs
Stress Reduction
Stroke
Weight Management
Today In Health History
Women's Health
Workplace Health
.
.
.
.
InteliHealth

   
.
.   HONcode
.
Chrome 2001
Chrome 2001